Bruker Corp. (NSDQ:BRKR) said today it inked a deal to pick up Oncovision‘s preclinical imaging business for an undisclosed amount. Oncovision will retain its clinical human imaging business, including its Mammi PET breast cancer diagnostic tool, the companies said. “With this planned acquisition, Bruker expects to strengthen its expertise and leadership in preclinical imaging. The […]
